Berkshire Hathaway Inc (BRYN)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 488.90 |
|---|---|
| 52-week range | 393.50 – 492.80 |
| Return, 1 month / 3 months | +10.4% / +12.0% |
| Return, 1 year / 3 years | +16.9% / +55.1% |
| Trend | Uptrend |
| RSI (14) | 82 |
| Volatility (1 year) | 15.5% |
| Worst drawdown (1 year) | -10.6% |
| Average daily value traded | 2.53M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Berkshire Hathaway is a holding company based in the United States that owns insurance businesses and a broad collection of operating companies. Its insurance operations write property, casualty and reinsurance policies for individuals and businesses. Other subsidiaries run a railroad, generate and distribute electricity, and make products ranging from building materials to consumer goods, while the parent also holds stakes in publicly traded companies.
Berkshire Hathaway Inc trades under the code BRYN on the Deutsche Börse Xetra in Germany, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Berkshire Hathaway Inc (BRYN) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 488.90 on 27 October 2026.
Its price-based Market X-Ray is 84 out of 100 (a strong price profile), ranking 6 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.9% and over the last three months it rose 12.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.1% | ||
| From 52-week high | -0.1% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 12.0% | ||
| 6-month return | 20.8% | ||
| 12-month return, skipping the last month | 5.9% | ||
| Stability (higher is calmer) | 98 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 15.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -10.6% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 2.53M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.1% |
|---|---|
| 1 month | +10.4% |
| 3 months | +12.0% |
| 6 months | +20.8% |
| 1 year | +16.9% |
| 3 years | +55.1% |
| 5 years | +96.0% |
Signals
| 50-day / 200-day average | 449.27 / 428.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.01 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.